Protozoan diseases: Toxoplasmosis

International Encyclopedia of Public Health

Volumn , Issue , 2008, Pages 382-394

  Petersen, E ^a   Salmi, R ^b   Chene G ^b   Thiebaut R ^b   Gilbert, R ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Congenital infections; Ocular disease; Opportunistic infections; Toxoplasmosis

Indexed keywords

EID: 84884454812     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012373960-5.00491-3     Document Type: Chapter

References (177)

1. Ahlfors K., Borjeson M., Huldt G., Forsberg E. Incidence of toxoplasmosis in pregnant women in the city of Malmo, Sweden. Scandinavian Journal of Infectious Diseases 1989, 21:315-321.
2. Ajzenberg D., Cogné N., Paris L., et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. Journal of Infectious Diseases 2000, 186:684-689.
3. Ajzenberg D., Banuls A.L., Su C., et al. Genetic diversity, clonality and sexuality in. Toxoplasma gondii. International Journal for Parasitology 2004, 34:1185-1196.
4. Alves C.F., Vitor R.W. Efficacy of atovaquone and sulfadiazine in the treatment of mice infected with Toxoplasma gondii strains isolated in Brazil. Parasite 2005, 12:171-177.
5. Ancelle T., Goulet V. La toxoplasmose chez la femme enceinte en France en 1995. Resultats d'une enquete nationale perinatale. Bulletin Epidemiologique Hebdomadaire 1996, 51:227-229.
6. Araujo F.G., Khan A.A., Bryskier A., Remington J.S. Use of ketolides in combination with other drugs to treat experimental toxoplasmosis. Journal of Antimicrobiol Chemotherapy 1998, 42:665-667.
7. Aspöck H. Prevention of congenital toxoplasmosis in Austria: Experience of 25 years. Congenital Toxoplasmosis 2000, 277-299. Springer-Verlag, Paris, France. P. Ambroise-Thomas, E. Petersen (Eds.).
8. Aspöck H. Prevention of congenital toxoplasmosis in Austria. Archives de Pediatrie 2003, 10(supplement 1):16-17.
9. Aspöck H., Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scandinavian Journal of Infectious Diseases. Supplementum 1992, 84:32-37.
10. Aubert G., Maine G.T., Villena I., et al. Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay. Journal of Clinical Microbiology 2000, 38:1144-1150.
11. Bahia-Oliveira L.M., Jones J.L., Azevedo-Silva J., Alves C.C., Orefice F., Addiss D.G. Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil. Emerg Infect Dis 2003, 9:55-62.
12. Bénard A., Salmi R. Systematic review of published data on the burden of congenital toxoplasmosis in Europe (accessed January 2008). http://eurotoxo.isped.u-bordeaux2.fr/.
13. Bénard A., Salmi R. Survey on the programs implemented in Europe for the epidemiological surveillance of congenital toxoplasmosis (accessed January 2008). http://eurotoxo.isped.u-bordeaux2.fr/.
14. Beringer T. Is toxoplasmosis diagnosis meaningful during prenatal care?. Geburtshlf Frauenheilkund 1992, 52:740-741.
15. Beverly J.K.A. A rational approach to the treatment of toxoplasma uveitis. Trans Ophthalmol Soc UK 1958, 78:109-121.
16. Binquet C., Wallon M., Quantin C., et al. Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis. Epidemiol Infect 2003, 131:1157-1168.
17. Binquet C., Wallon M., Metral P., Gadreau M., Quantin C., Peyron F. Toxoplasmosis seroconversion in pregnant women. The differing attitudes in France. Presse Med 2004, 33:775-779.
18. Boothroyd J.C., Grigg M.E. Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease?. Curr Opin Microbiol 2002, 54:38-42.
19. Bosch-Driessen L.H., Verbraak F.D., Suttorp-Schulten M.S., et al. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. Am J Ophthalmol 2002, 134:34-40.
20. Bowie W.R., King A.S., Werker D.H., et al. Outbreak of toxoplasmosis associated with municipal drinking water. The BC Toxoplasma Investigation Team. The Lancet 1997, 350:173-177.
21. Breugelmans M., Naessens A., Foulon W. Prevention of toxoplasmosis during pregnancy-an epidemiologic survey over 22 consecutive years. J Perinat Med 2004, 32:211-214.
22. Buffolano W., Gilbert R.E., Holland F.J., Fratta D., Palumbo F., Ades A.E. Risk factors for recent toxoplasma infection in pregnant women in Naples. Epidemiol Infect 1996, 116:347-351.
23. Burnett A.J., Shortt S.G., Isaac-Renton J., King A., Werker D., Bowie W.R. Multiple cases of acquired toxoplasmosis retinitis presenting an outbreak. Ophthalmol 1998, 105:1032-1037.
24. Carme B., Bissuel F., Ajzenberg D., et al. Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana. J Clin Microbiol 2002, 40:4037-4044.
25. Chandrasekar P.H., Momin F.J. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transpl 1997, 19:685-689. Bone Marrow Transplant Team.
26. Charpiat B., Thiébaut R., Salmi L.R. Systematic review of published pharmacokinetic data related to pyrimethamine (accessed January 2008). http://eurotoxo.isped.u-bordeaux2.fr/.
27. Charpiat B., Thiébaut R., Salmi L.R. Systematic review of published pharmacokinetic data related to sulfadiazine (accessed January 2008). http://eurotoxo.isped.u-bordeaux2.fr/.
28. Charpiat B., Thiébaut R., Salmi L.R. Systematic review of published pharmacokinetic data related to sulfadoxine (accessed January 2008). http://eurotoxo.isped.u-bordeaux2.fr/.
29. Charpiat B., Thiébaut R., Salmi L.R. Systematic review of published pharmacokinetic data related to spiramycine (accessed January 2008). http://eurotoxo.isped.u-bordeaux2.fr/.
30. Conyn-van Spaedonck M.A., van Knapen F. Choices in preventive strategies: experience with the prevention of congenital toxoplasmosis in The Netherlands. Scand J Infect Dis 1992, 84(Suppl.):51-58.
31. Cook A.J., Gilbert R.E., Buffolano W., et al. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. European Research Network on Congenital Toxoplasmosis. Br Med J 2000, 321:142-147.
32. Couvreur J. Étude de la toxoplasmose congenitale à propo de 20 observations 1955, Sorbonne, Paris, PhD thesis.
33. Couvreur J. Étude de la toxoplasmose congenitale à propo de 20 observation 1962, These. Paris,1955. Sorbonne University.
34. Couvreur J., Desmonts G. Congenital and maternal toxoplasmosis. A review of 300 cases. Develop Med Chld Neurol 1962, 4:519-530.
35. Daveluy A., Haramburu F., Fourrier A., Thiébaut R. Review of data related to side effects of drugs used in congenital yoxoplasmosis (2) (accessed January 2008). http://eurotoxo.isped.u-bordeaux2.fr/.
36. Daveluy A., Haramburu F., Bricout H., et al. Review of data related to side effects of drugs used in congenital yoxoplasmosis (accessed January 2008). http://eurotoxo.isped.u-bordeaux2.fr.
37. Decoster A., Darcy F., Caron A., et al. Anti-P30 IgA antibodies as prenatal markers of congenital toxoplasma infection. Clin Exp Immunol 1992, 87:310-315.
38. Derouin F. Systematic search and analysis of preclinical published data on in vitro and in vivo activities of antitoxoplasma drugs (accessed January 2008). http://eurotoxo.isped.u-bordeaux2.fr/.
39. Derouin F., Caroff B., Chau F., Prokocimer P., Pocidalo J.J. Synergistic activity of clarithromycin and minocycline in an animal model of acute experimental toxoplasmosis. Antimicrob Agents Chemother 1992, 36:2852-2855.
40. Desmonts G., Couvreur J. Congenital toxoplasmosis: a prospective study of 378 pregnancies. N Engl J Med 1974, 290:1110-1116.
41. Desmonts G., Couvreur J., Ben Rachid M.S. Le toxoplasme, la mère et l'enfant. Arch Franç Pédiatr 1965, 22:1183-1200.
42. Dias R.A., Navarro I.T., Ruffolo B.B., Bugni F.M., Castro M.V., Freire R.L. Toxoplasma gondii in fresh pork sausage and seroprevalence in butchers from factories in Londrina, Parana State, Brazil. Rev Inst Med Trop Sao Paulo 2005, 47:185-189.
43. Dubey J.P. until rates of congenital toxoplasmosis fall, control measures are essential. Br Med J 2000, 321:127-128. Sources of Toxoplasma gondii infection in pregnancy.
44. Dunn D., Wallon M., Peyron F., Petersen E., Peckham C.S., Gilbert R.E. Mother to child transmission of toxoplasmosis: risk estimates for clinical counselling. The Lancet 1999, 353:1829-1833.
45. Eichenwald H.F. Congenital toxoplasmosis: a study of 150 cases. Am J Dis Chld 1957, 94:411-412.
46. Elnahas A., Gerais A.S., Elbashir M.I., Eldien E.S., Adam I. Toxoplasmosis in pregnant Sudanese women. Saudi Med J 2003, 24:868-870.
47. Enzensberger W., Helm E.B., Hopp G., Stille W., Fischer P.A. Toxoplasma encephalitis in patients with AIDS. Dtsch Med Wochenschr 1985, 110:83-87.
48. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 2003, 110:112-120. European Multicentre Study on Congenital Toxoplasmosis.
49. Gilbert R., Chene G. EUROTOXO, (accessed January 2008). http://eurotoxo.isped.u-bordeaux2.fr/.
50. Evengard B., Petersson K., Engman M.L., et al. Low incidence of toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 2001, 127:121-127.
51. Eyles D.E. The present status of the chemotherapy of Toxoplasmosis. Am J Trop Med Hyg 1953, 2:429-444.
52. Eyles D.E., Coleman M. Tests of 2,4-diamonopyrimidines on toxoplasmosis. Pub Hlth Rep 1952, 67:249-252.
53. Eyles D.E., Coleman M. Synergistic effect of sulfadiazine and daraprim against Toxoplasmosis in mice. Antibiot Chemother 1953, 3:483-490.
54. Fan C.K., Hung C.C., Su K.E., et al. Seroprevalence of Toxoplasma gondii infection among pre-school children aged 1-5 years in the Democratic Republic of Sao Tome and Principe, Western Africa. Trans R Soc Trop Med Hyg 2005, 101:1157-1158.
55. Feldman H.A. Congenital toxoplasmosis - a study of 103 cases. Am J Dis Child 1953, 86:487.
56. Ferreira Ade M., Vitor R.W., Gazzinelli R.T., Melo M.N. Genetic analysis of natural recombinant Brazilian Toxoplasma gondii strains by multilocus PCR-RFLP. Infect Genet Evol 2006, 6:22-31.
57. Flament-Durand J., Coers C., Waelbroeck C., Geertruyden J., van Tousaint C. Toxoplasmic encephalitis and myositis during treatment with immunodepressive drugs. Acta Clin Belg 1967, 22:44-54.
58. Forsgren M., Gille E., Ljungstrom I. Toxoplasma antibodies in pregnant women in Sweden in 1969, 1979 and 1987. The Lancet 1991, 337:1413-1414.
59. Foulon W., Naessens A., Volckaert M., Lauwers S., Amy J.J. Congenital toxoplasmosis: a prospective survey in Brussels. Br J Obstet Gynaecol 1984, 91:419-423.
60. Frenkel J.K., Ruiz A., Chinchilla M. Soil survival of toxoplasma oocysts in Kansas and Costa Rica. Am J Trop Med Hyg 1975, 24:439-443.
61. Gallino A., Maggiorini M., Kiowski W., et al. Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis 1996, 15:389-393.
62. Garin J.P., Eyles D.E. Le traitement de la toxoplasmose expérimentale de la souris par la spiramycine. Nouv Presse Méd 1958, 66:254-260.
63. Garin J.P., Sung R.T.M., Mojon M., Paillard B. Guérison de la toxoplasmose expérimentale de la souris par l'association sulfadoxine-pyrimethamine. Propositions d'application à l'homme. Lyon Med 1976, 236:19-23.
64. Gilbert R.E., Stanford M.R. Is ocular toxoplasmosis caused by prenatal or postnatal infection?. Br J Ophthalmol 2000, 84:224-226.
65. Gilbert R.E., Stanford M.R., Jackson H., et al. Incidence of acute, symptomatic Toxoplasma retinochoroiditis in south London according to country of birth. Br Med J 1995, 310:1037-1040.
66. Gilbert R.E., Dunn D.T., Lightman S., et al. Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect 1999, 123:283-289.
67. Gilbert R.E., Dunn D., Wallon M., et al. Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment period. Epidemiol Infect 2001, 127:113-120.
68. Gilbert R.E., Gras L. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. BJOG 2003, 110:112-120. the European Multicentre, Study on Congenital, Toxoplasmosis.
69. Giordano L.F.C.M., Lasmar E.P., Tavora E.R.F., Lasmar M.F. Toxoplasmosis transmitted via kidney allograft: case report and review. Transplant Proc 2002, 34:498-499.
70. Glasner P.D., Silveira C., Kruszon-Moran D., et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol 1992, 114:136-144.
71. Gollub E.L., Leroy V., Gilbert R., Chêne G., Wallon M. Effectiveness of health education approaches for primary prevention of congenital toxoplasmosis (accessed January 2008. http://eurotoxo.isped.u-bordeaux2.fr/.
72. Gormley P.D., Pavesio C.E., Minnasian D., Lightman S. Effects of drug therapy on Toxoplasma cysts in an animal model of acute and chronic disease. Invest Ophthalmol Vis Sci 1998, 39:1171-1175.
73. Gras L., Gilbert R.E., Ades A.E., Dunn D.T. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol 2001, 30:1309-1313.
74. Gras L., Gilbert R.E., Wallon M., Peyron F., cortina-Borja M. Duration of the lgm response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiology and Infection 2004, 132:541-548.
75. Gras L., Wallon M., Pollak A., et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centers. Acta Pediatrica 2005, 94:1721-1731. for TheEuropean, Multicenter Study on Congenital, Toxoplasmosis.
76. Grigg M.E., Bonnefoy S., Hehl A.B., Suzuki Y., Boothroyd J.C. Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries. Science 2001, 294:161-165.
77. Guerina N.G., Hsu H.W., Meissner H.C., et al. Neonatal serologic screening and early treatment for congenital T. gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1944, 330:1858-1863.
78. Guerina N.G., Hsu H.W., Meissner H.C., et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. New England Journal of Medicine 1994, 330:1858-1863.
79. Hejlicek K., Literak I., et al. Toxoplasma gondii antibodies in pregnant women in the Ceske Budejovice District. Epidemiol Mikrobiol Imunol 1999, 48:102-105.
80. Hill D., Dubey J.P. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect 2002, 8:634-640.
81. Hlobil H., Gultig K. Congenital toxoplasma infections in Baden-Wurttemberg. Klinisches Labor 1992, 38:679-686.
82. Hogan M.J. Ocular toxoplasmosis in adult patients. Surv Ophthalmol 1961, 6:935-951.
83. Hogan M.J., Kimura S.J., O'Connor G.R. Ocular toxoplasmosis. Arch Ophthalmol 1964, 72:592-600.
84. Holland G.N. Ocular toxoplasmosis: A global reassessment. Part I: Epidemiology and course of disease. Am J Ophthalmol 2003, 136:973-988.
85. Holmdahl S.C., Holmdahl K. The frequency of congenital toxoplasmosis and some viewpoints on the diagnosis. Acta Paediatr 1955, 44:322-329.
86. Horion M., Thoumsin H., Senterre J., Lambotte R. 20 years of screening for toxoplasmosis in pregnant women. The Liege experience in 20,000 pregnancies. Rev Med Liege 1990, 45:492-497.
87. Howe D.K., Honore S., Derouin F., Sibley L.D. Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol 1997, 35:1411-1414.
88. Hung C.C., Chen M.Y., Hsieh S.M., Hsiao C.F., Sheng W.H., Chang S.C. Prevalence of Toxoplasma gondii infection and incidence of toxoplasma encephalitis in non-haemophiliac HIV-1-infected adults in Taiwan. Int J STD AIDS 2005, 16:302-306.
89. Huskinson-Mark J., Araujo F.G., Remington J.S. Evaluation of the effect of drugs on the cyst form of. Toxoplasma gondii. J Infect Dis. 1991, 164:170-171.
90. Janitschke K. Official recommendations and strategy for prevention of congenital toxoplasmosis in Germany. Arch Pediatr 2003, 10(Suppl 1):15.
91. Janku J. Pathogenesa a patologicka anatomie tak nazvaneho vrozenehonalezem parasitu v sitnici. Cas Lek Ces 1923, 62:1021-1027.
92. Jeannel D., Niel G., Costagliola D., Danis M., Traore B.M., Gentilini M. Epidemiology of toxoplasmosis among pregnant women in the Paris ares. Intl J Epidemiol 1988, 17:595-602.
93. Jeannel D., Niel G., Costagliola D., Danis M., Traore B.M., Gentilini M. Prevalence of Toxoplasma gondii specific immunoglobulin G antibodies among pregnant women in Norway. Epidemiol Infect 1998, 120:87-92.
94. Jenum P.A., Stray-Pedersen B., Melby K.K., et al. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 1998, 36:2900-2906.
95. Jones J.L., Kruszon-Moran D., Wilson M. Toxoplasma gondii infection in the United States, 1999-2000. Emerg Infect Dis 2003, 9:1371-1374.
96. Jones J.L., Lopez B., AlvarezMury M., et al. Toxoplasma gondii infection in rural Guatemalan children. Am J Trop Med Hyg 2005, 72:295-300.
97. Joynson D.H. Congenital toxoplasma infection in the UK. Arch Pediatr 2003, 10(Suppl 1):27-28.
98. Kapperud G., Jenum P.A., Stray-Pedersen B., Melby K.K., Eskil A., Eng J. Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway. Am J Epidemiol 1996, 144:405-412.
99. Khan A., Taylor S., Su C., et al. Composite genome map and recombination parameters derived from three archetypal lineages of Toxoplasma gondii. Nucleic Acids Res 2005, 33:2980-2992.
100. Khoshnood B., Vigan D., de Goffinet F., Leroy V. Prenatal screening and diagnosis of congenital toxoplasmosis: A review of safety issues and psychological consequences for women who undergo screening (accessed January 2008). http://eurotoxo.isped.u-bordeaux2.fr/.
101. Kimball A.C., Kean B.H., Fuchs F. Congenital toxoplasmosis: a prospective study of 4,048 obstetric patients. Am J Obstet Gynaecol 1971, 111:211-218.
102. Kong J.T., Grigg M.E., Uyetake L., Parmley S., Boothroyd J.C. Serotyping of Toxoplasma gondii infections in humans using synthetic peptides. J Infect Dis 2003, 187:1484-1495.
103. Krausse T., Straube W., Wiersbitzky S., Hitz V., Kewitsch A. Screening for toxoplasmosis in pregnancy - a pilot program in Northeast Germany. Geburtshilfe Frauenheilkd 1993, 53:613-618.
104. Lappalainen M. Current situation regarding toxoplasmosis in Finland. Arch Pediatr 2003, 10(Suppl 1):19.
105. Lappalainen M., Koskela P., Hedman K., et al. Incidence of primary toxoplasma infections during pregnancy in southern Finland: a prospective cohort study. Scand J Infect Dis 1992, 24:97-104.
106. Lebech M., Petersen E., Larsen S.O. Prevalence, incidence and geographical distribution of Toxoplasma gondii antibodies in pregnant women in Denmark. Scand J Infect Dis 1993, 25:751-756.
107. Lebech M., Andersen O., Christensen N.C., et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. The Lancet 1999, 353:1834-1837. the Danish Congenital, Toxoplasmosis Study, Group.
108. Leroy V., Hadjichristodoulou C. Systematic review of risk factors for Toxoplasma gondii infection in pregnant women (accessed January 2008). http://eurotoxo.isped.u-bordeaux2.fr/.
109. Leroy V., Harambat J., Perez P., Rudin C., Gilbert R., Petersen E. (accessed January 2008). http://eurotoxo.isped.u-bordeaux2.fr/.
110. Liesenfeld O., Press C., Montoya J.G., et al. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 1997, 35:174-178.
111. Liesenfeld O., Montoya J.G., Kinney S., Press C., Remington J.S. Effect of testing for IgG avidity in the diagnosis of T. gondii infection in pregnant women: experience in a U.S. reference laboratory. J Infect Dis 2001, 183:1248-1253.
112. Liesenfeld O., Montoya J.G., Kinney S., Press C., Remington J.S. Confirmatory serological testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers. Am J Obstet Gynecol 2001, 184:140-145.
113. Logar J., Novak-Antolic Z., Zore A. Serological screening for toxoplasmosis in pregnancy in Slovenia. Scand J Infect Dis 1995, 27:163-164.
114. Logar J., Petrovec M., Novak-Antolic Z., et al. Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women. Scand J Infect Dis 2002, 34:201-204.
115. Lopez A., Dietz V.J., Wilson M., Navin T.R., Jones J.L. Preventing congenital toxoplasmosis. MMWR Morbodity and Mortality Weekly Report 2000, 49:59-68.
116. Luft B.J., Conley F., Remington J.S. Outbreak of central nervous system toxoplasmosis in Western Europe and North America. The Lancet 1983, ii:781-784.
117. Luyasu V., Robert A., Lissenko D., Bertrand M., Bohy E., Wacquez M., De Bruyere M. A seroepidemiological study on toxoplasmosis. Acta Clin Belg 1997, 52:3-8.
118. Maetz H.M., Kleinstein R.N., Frederico D., Wayne J. Estimated prevalence of ocular toxoplasmosis and toxocariasis in Alabama. J Infect Dis 1987, 156:414.
119. Martino R., Bretagne S., Einsele H., et al. Early detection of Toxoplasma infection by molecular monitoring of T. gondii in peripheral blood samples after allogenic stem cell transplantation. Clin Infect Dis 2005, 40:67-78. and the Infectious Disease, Working Party of the European, Group for Blood, Marrow Transplantation.
120. McCabe R., Remington J.S. Toxoplasmosis: the time has come. N Engl J Med 1988, 318:313-315.
121. McLeod R., Boyer K., Karrison T., et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin Infect Dis 2006, 42:1383-1394. Toxoplasmosis Study, Group.
122. McQuillan G.M., Kruszon-Moran D., Kottiri B.J., Curtin L.R., Lucas J.W., Kington R.S. Racial and ethnic differences in the seroprevalence of 6 infectious diseases in the United States: data from NHANES III, 1988-1994. Am J Public Health 2004, 94:1952-1958.
123. Mele A., Paterson P.J., Prentice H.G., Leoni P., Kibbler C.C. Toxoplasmosis in bone marrow transplantation: a report of two cases and systematic review of the literature. Bone Marrow Transplant 2002, 29:691-698.
124. Millogo A., Ki-Zerbo G.A., Traore W., Sawadogo A.B., Ouedraogo I., Peghini M. Toxoplasma serology in HIV infected patients and suspected cerebral toxoplasmosis at the Central Hospital of Bobo-Dioulasso (Burkina Faso). Bull Soc Pathol Exot 2000, 93:17-19.
125. Neto E.C., Rubin R., Schulte J., Giugliani R. Newborn screening for congenital infectious diseases. Emerg Infect Dis 2004, 10:1068-1073.
126. Nissapatorn V., Noor-Azmi M.A., Cho S.M., et al. Toxoplasmosis: prevalence and risk factors. J Obstet Gynaecol 2003, 23:618-624.
127. Nissapatorn V., Lee C., Quek K.F., Leong C.L., Mahmud R., Abdullah K.A. Toxoplasmosis in HIV/AIDS patients: a current situation. Jpn J Infect Dis 2004, 57:160-165.
128. Orr K.E., Gould F.K., Short G., et al. Outcome of T. gondii mismatches in heart transplant recipients over a period of 8 years. J Infect 1994, 29:249-253.
129. Paivonsalo-Hietanen T., Tuominen J., Saari K.M. Uveitis in children: Population-based study in Finland. Acta Ophthalmol Scand 2000, 78:84-88.
130. Paul M., Petersen E., Szczapa J. Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznan region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies. J Clin Microbiol 2001, 39:1912-1916.
131. Perkins E.S., Schofield P.B., Smith C.H. Treatment of uveitis with pyrimethamine (daraprim). Br J Ophthalmol 1956, 40:577-586.
132. Petersen E., Schmidt D.R. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options?. Expert Rev Anti Infect Ther 2003, 1:175-182.
133. Peyron F., Lobry J., Muret K., et al. Serotyping of Toxoplasma gondii in pregnant women. Predominance of type II in the old world and type I and III in the new world. Microbial Infections 2006, 8:2333-2340.
134. Peyron F., Wallon M., Liou C., Garner P. Treatments for toxoplasmosis in pregnancy. Cochrane Database Syst Rev 2000, 2. CD001684.
135. Remington J.S., Miller M.J., Brownlee I. IgM antibodies in acute toxoplasmosis. I. Diagnostic significance in congenital cases and a method for their rapid demonstration. Pediatr 1968, 41:1082-1091.
136. Renoult E., Georges E., Biava M.F., et al. Toxoplasmosis in kidney transplant recipients: report of six cases and review. Clin Infect Dis 1997, 24:625-634.
137. Ricci M., Pentimalli H., Thaller R., Rava L., DiCiommo V. Screening and prevention of congenital toxoplasmosis: An effectiveness study in a population with a high infection rate. J Matern Fetal Neonatal Med 2003, 14:398-403.
138. Robert A., Luyasu V., Zuffrey J., Hedman K., Petersen E. Potential of the specific markers in the early diagnosis of Toxoplasma-infection: A multicentre study using combination of isotype IgG, IgM, IgA and IgE with values of avidity assay. Eur J Clin Microbiol Infect Dis 2001, 20:467-474. European Network on Congenital Toxoplasmosis.
139. Ronday M.J., Stilma J.S., Barbe R.F., et al. Aetiology of uveitis in Sierra Leone, west Africa. Blindness from uveitis in a hospital population in Sierra Leone. Br J Ophthalmol 1996, 80:956-961.
140. Roos T., Martius J., Gross U., Schrod L. Systematic serologic screening for toxoplasmosis in pregnancy. Obstet Gynecol 1993, 81:243-250.
141. Rothova A., Meenken C., Buitenhuis H.J., et al. Therapy for ocular toxoplasmosis. Am J Ophthalmol 1993, 115:517-523.
142. Roue R., Debord T., Denamur E., et al. Diagnosis of Toxoplasma encephalitis in absence of neeurological signs by early computerised tomography scanning in patients with AIDS. The Lancet 1984, 2(8417-18):1472.
143. Sabin A.B. Toxoplasmic encephalitis in children. J Am Med Assoc 1941, 116:801-807.
144. Sarciron M.E., Saccharin C., Petavy A.F., Peyron F. Effects of artesunate, dihydroartemisinin, and an artesunate-dihydroartemisinin combination against Toxoplasma gondii. Am J Trop Med Hyg 2000, 62:73-76.
145. Schurmann D., Bergmann F., Albrecht H., et al. Effectiveness of twice-weekly pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection. Eur J Clin Microbiol Infect Dis 2002, 21:353-361.
146. Sibley L.D., Boothroyd J.C. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature 1992, 359:82-85.
147. Silveira C., Belfort R., Muccioli C., et al. A follow-up study of Toxoplasma gondii infection in southern Brazil. Am J Ophthalmol 2001, 131:351-354.
148. Silveira C., Belfort R., Muccioli C., et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 2002, 134:41-46.
149. Singh S., Pandit A.J. Incidence and prevalence of toxoplasmosis in Indian pregnant women: a prospective study. Am J Reprod Immunol 2004, 52:276-283.
150. Smith R.E., Ganley J.P. Ophthalmic survey of a community. I. Abnormalities of the ocular fundus. Am J Ophthalmol 1972, 74:1126-1130.
151. Song K.J., Shin J.C., Shin H.J., Nam H.W. Seroprevalence of toxoplasmosis in Korean pregnant women. Korean J Parasitol 2005, 43:69-71.
152. Sørensen T., Spenter J., Jaliashvili I., Christiansen M., Nørgarrd-Pedersen B., Petersen E. An automated time-resolved immunofluometric assay for detection of Toxoplasma gondii specific IgM and IgA antibodies in filterpaper samples from newborns. Clin Chemistry 2002, 48:1981-1986.
153. Stanford M.R., See S.E., Jones L.V., Gilbert R.E. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review. Ophthalmol 2003, 110:926-931.
154. Stray-Pedersen B. Prevention of congenital toxoplasmosis in Norway. Arch Pediatr 2003, 10(Suppl 1):23-24.
155. Su C., Evans D., Cole R.H., Kissinger J.C., Ajioka J.W., Sibley L.D. Recent expansion of Toxoplasma through enhanced oral transmission. Science 2003, 299:353-354.
156. Sukthana Y., Kaewkungwal J., Jantanavivat C., Lekkla A., Chiabchalard R., Aumarm W. Toxoplasma gondii antibody in Thai cats and their owners. South East Asian J Trop Med Public Health 2003, 34:733-738.
157. Suzuki Y., Israelski D.M., Dannemann B.R., Stepick-Biek P., Thulliez P., Remington J.S. Diagnosis of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome by using a new serological method. J Clin Microbiol 1988, 26:2541-2543.
158. Szenasi Z., Ozsvar Z., Nagy E., et al. Prevention of congenital toxoplasmosis in Szeged, Hungary. Int J Epidemiol 1997, 26:428-435.
159. Thiébaut R., Bricout H., Costanzo S., di, Mouillet E. Systematic review of published studies evaluating postnatal treatment effect (accessed January 2008). http://eurotoxo.isped.u-bordeaux2.fr/.
160. Thiébaut R., Leroy V., Alioum A., et al. Biases in observational studies of the effect of prenatal treatment for congenital toxoplasmosis. Eur J Obstet Gynecol Reprod Biol 2006, 124:3-9.
161. Thiébaut R., et al. Individual patient data meta-analysis of prenatal treatment effect for congenital toxoplasmosis on behalf of SYROCOT (Systematic, Review on Congenital, Toxoplasmosis) Investigators, (accessed January 2008). http://www.isped.u-bordeaux2.fr/RECHERCHE/SYROCOT/SYROCOT.pdf.
162. Thulliez P. Screening programme for congenital toxoplasmosis in France. Scand J Infect Dis 1992, 84(Suppl.):43-45.
163. Torrey E.F., Yolken R.H. Toxoplasma gondii and schizophrenia. Emerg Infect Dis 2003, 9:1375-1380.
164. Vallochi A.L., Muccioli C., Martins M.C., Silveira C., Belfort R., Rizzo L.V. The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am J Ophthalmol 2005, 139:350-351.
165. Villena I., Aubert D., Leroux B., et al. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis 1998, 30:295-300.
166. Wallon M., Cozon G., Ecochard R., Lewin P., Peyron F. Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children. Eur J Pediatr 2001, 160:534-540.
167. Welton N.J., Ades A.E. A model of toxoplasmosis incidence in the UK: Evidence synthesis and consistency of evidence. Journal of the Royal Statistical Society: Series C (Applied Statistics) 2005, 54(2):385-404.
168. Wilder H.C. Toxoplasma chorioretinitis in adults. Arch Ophthalmol 1952, 48:127-136.
169. Williams K.A., Scott J.M., Macfarlane D.E., Williamson J.M., Elias-Jones T.F., Williams H. Congenital toxoplasmosis: a prospective survey in the West of Scotland. J Infect 1981, 3:219-229.
170. Wreghitt T.G., Gray J.J., Pavel P., et al. Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart and heart-lung transplant patients. Transpl Int 1992, 5:197-200.
171. Wulf M.W.H., Crevel R., van, Portier R., et al. Toxoplasmosis after renal transplantation: Implications of a missed diagnosis. J Clin Microbiol 2005, 43:3544-3547.
172. Antoniou M., Tzouvali H., Sifakis S., et al. Incidence of toxoplasmosis in 5532 pregnant women in Crete, Greece: Management of 185 cases at risk. European Journal of Obstetrics, Gynecology, and Reproducitve Biology 2004, 117:138-143.
173. Baril L., Ancelle T., Goulet V., Thulliez P., Tirard-Fleury V., Carme B. Risk factors for Toxoplasma infection in pregnancy: A case-control study in France. Scandinavian Journal of Infectious Diseases 1999, 31:305-309.
174. Berger R., Merkel S., Rudin C. Toxoplasmosis and pregnancy - findings from umbilical cord blood screening in 30,000 newborn infants. Schweizerische medizinische Wochenschrift 1995, 125:1168-1173.
175. Foulon W., Naessens A., Lauwers S., DeMeuter F., Amy J.J. Impact of primary prevention on the incidence of toxoplasmosis during pregnancy. Obstetrics and Gynecology 1988, 72:363-366.
176. Signorell L.M., Seitz D., Merkel S., Berger R., Rudin C. Cord blood screening for congenital toxoplasmosis in northwestern Switzerland 1982-1999. Pediatric Infectious Disease Journal 2006, 25:123-128.
177. Wallon M., Liou C., Garner P., Peyron F. Congenital toxoplasmosis: Systematic review of evidence of efficacy of treatment in pregnancy. British Medical Journal 1999, 318:1511-1514.